Back to Results
First PageMeta Content
Organochlorides / Carboxylic acids / Piperazines / Enantiopure drugs / Cetirizine / Levocetirizine / Methadone / Food and Drug Administration / Chemistry / Organic chemistry / Ethers


022064_Levocetirizine_Clinical_BPCAs
Add to Reading List

Open Document

File Size: 96,65 KB

Share Result on Facebook

Company

UCB Inc. / Introduction UCB Inc. / ITT / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

machinery / final product / administered product / mg/mL products / age / manufacturing process / /

MedicalCondition

uncomplicated skin manifestations / Pulmonary / diseases / skin manifestations / same diseases / Seasonal and perennial allergic rhinitis / chronic idiopathic urticaria / /

Organization

FDA / Advisory Committee / /

Person

Badrul A. Chowdhury / /

Position

Physician / Director Summary Review NDA Number Division / representative / Director / Division of Pulmonary and Allergy Products / /

Product

Xyzal / Xyzal 5 mg / Controls Xyzal 5 mg / Xyzal solution / Xyzal oral / Xyzal tablet / Controls Xyzal / /

RadioStation

Xyzal 1.25 QD AM / /

Technology

simulation / /

SocialTag